https://www.selleckchem.com/products/A014418.html
Other symptoms persisted in a lower percentage of patients in the 'recommended' than in the 'control' cohort (23·3% versus 73·3%, respectively, 0·0001) and for a shorter period ( =0·0107). Two patients in the 'recommended' cohort were hospitalised compared to 13 (14·4%) controls ( =0·0103). The prevention algorithm reduced the days and cumulative costs of hospitalisation by 90%. Implementation of an early home treatment algorithm failed to accelerate recovery from major symptoms of COVID-19, but reduced the risk of hospitalisati
Like
Comment
Share
